Home NDC 46122-531 Allergy Relief
Product NDC 46122-531
11-digit product format 461220531
Labeler code 46122
Product ID 46122-531_7dc5bf93-f17c-3267-33d9-f123f53c072b
Type HUMAN OTC DRUG
Nonproprietary name levocetirizine dihydrochloride
Dosage form TABLET, COATED
Route ORAL
Labeler AMERISOURCEBERGEN DRUG CORPORATION
Application ANDA210375
Marketing category ANDA
Marketing start 2018-04-20
Substance LEVOCETIRIZINE DIHYDROCHLORIDE
Active strength 5 mg/1
Pharmacologic classes Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 2 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Product NDC Package NDC Code Status Reporting period Archive Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 46122-531 46122-531-52 D Discontinued by firm excluded / ndc_excluded.zip d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 46122-531 46122-531-52 D Discontinued by firm excluded / ndc_excluded.zip f5e01cc5f278…a2eaf40c39c3…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A210375-001 LEVOCETIRIZINE DIHYDROCHLORIDE 5MG TABLET / ORAL 2018-01-19 e64feba35796…
Additional Listing Data#
Finished product Yes
Brand name base Allergy Relief
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength LEVOCETIRIZINE DIHYDROCHLORIDE 5 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination SOD6A38AGA Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 855172 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 46122-531-05 Allergy Relief 35 in 1 BOTTLE TABLET, COATED 35 10 46122-531-05 Allergy Relief 1 in 1 CARTON TABLET, COATED 1 10 46122-531-52 Allergy Relief 2 in 1 CARTON TABLET, COATED 2 10 46122-531-52 Allergy Relief 5 in 1 BLISTER PACK TABLET, COATED 5 10 46122-531-61 Allergy Relief 1 in 1 CARTON TABLET, COATED 1 10 46122-531-61 Allergy Relief 80 in 1 BOTTLE TABLET, COATED 80 10
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 46122-531 ALLERGY RELIEF (LEVOCETIRIZINE DIHYDROCHLORIDE) TABLET, COATED [AMERISOURCEBERGEN DRUG CORPORATION] 8 Current NDC, Legacy NDC, 6 package rows 20250521_fdf54de3-16a9-3b28-b4c4-d745322b3d3c.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 16 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 46122-531-05 46122053105 1 BOTTLE in 1 CARTON (46122-531-05) / 35 TABLET, COATED in 1 BOTTLE 1 bottle 2018-04-20 0000-00-00 No No Current 46122-531-52 46122053152 2 BLISTER PACK in 1 CARTON (46122-531-52) > 5 TABLET, COATED in 1 BLISTER PACK 2 blister pack 2018-07-06 0000-00-00 No No Current 46122-531-61 46122053161 1 BOTTLE in 1 CARTON (46122-531-61) / 80 TABLET, COATED in 1 BOTTLE 1 bottle 2023-09-01 No No Current